Gubra A S (GUBRF) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gubra A/s.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.381 -- 00:00:05.766 Thank you for standing by. My name is Gail, and I will be your operator for today. 00:00:05.766 -- 00:00:09.851 At this time, I would like to welcome each and every one of you to the group first quarter 00:00:09.851 -- 00:00:15.618 2025 earnings release. All lines have been placed on mute to prevent any background noise. 00:00:15.618 -- 00:00:19.603 After the speech remarks, there will be a question and answer session. 00:00:19.603 -- 00:00:23.508 If you would like to ask a question during this time, simply press star followed by the 00:00:23.508 -- 00:00:27.833 number one on your telephone keypad. If you would like to withdraw your question, kindly 00:00:27.833 -- 00:00:32.638 press star one again. Thank you. It is now my pleasure to turn today's call over to Gubre 00:00:32.638 -- 00:00:36.705 to start the presentation. Please go ahead. 00:00:36.992 -- 00:00:43.010 Thank you very much, Operator. It's our pleasure today to present first quarter 00:00:43.010 -- 00:00:45.953 results for you. 00:00:49.238 -- 00:00:53.243 Starting out, GUPRA is a hybrid business model company. 00:00:53.243 -- 00:00:58.308 We are experts in preclinical research into metabolic 00:00:58.308 -- 00:01:03.454 disease and neighboring scientific areas. We have built a 00:01:03.454 -- 00:01:09.421 core research accelerator, meaning we have all the labs and testing facilities in-house 00:01:09.421 -- 00:01:13.345 in order to progress preclinical programs. 00:01:13.345 -- 00:01:19.055 And this core research accelerator we use to provide services 00:01:19.055 -- 00:01:21.982 to external clients 00:01:21.982 -- 00:01:27.013 as well as to mature our internal research programs so that 00:01:27.013 -- 00:01:32.366 is the cro business the external clients and the pipel...